Caudate volumes in childhood predict symptom severity in adults with Tourette syndrome.

Child Study Center, Yale University School of Medicine, New Haven, CT, USA.
Neurology (Impact Factor: 8.3). 11/2005; 65(8):1253-8. DOI: 10.1212/01.wnl.0000180957.98702.69
Source: PubMed

ABSTRACT Most children with Tourette syndrome (TS) experience a marked decline in the severity of tic symptoms during adolescence. Currently no clinical measures can predict whose tic symptoms will persist into adulthood. Previous cross-sectional imaging studies have identified reduced caudate nucleus volumes in subjects with TS.
To evaluate whether caudate nucleus volumes in childhood can predict the severity of tic or obsessive-compulsive symptoms at follow-up in early adulthood.
In a prospective longitudinal study, clinical status and basal ganglia volumes of 43 children with TS were measured on high-resolution magnetic resonance images before age 14 years. Follow-up clinical assessments were conducted after age 16 years, an average of 7.5 years later. Linear regression and Tobit regression analyses were used to assess the association of basal ganglia volumes measured in childhood with the severity of tic and obsessive-compulsive disorder (OCD) symptoms at the time of childhood MRI and at follow-up in early adulthood.
Volumes of the caudate nucleus correlated significantly and inversely with the severity of tic and OCD symptoms in early adulthood. Caudate volumes did not correlate with the severity of symptoms at the time of the MRI scan.
Caudate volumes in children with Tourette syndrome predict the severity of tic and obsessive-compulsive symptoms in early adulthood. This study provides compelling evidence that morphologic disturbances of the caudate nucleus within cortico-striatal-thalamo-cortical circuits are central to the persistence of both tics and obsessive-compulsive symptoms into adulthood.

  • [Show abstract] [Hide abstract]
    ABSTRACT: This review presents state-of-the-art knowledge about the roles of the basal ganglia (BG) in action-selection, cognition, and motivation, and how this knowledge has been used to improve deep brain stimulation (DBS) treatment of neurological and psychiatric disorders. Such pathological conditions include Parkinson's disease, Huntington's disease, Tourette syndrome, depression, and obsessive-compulsive disorder. The first section presents evidence supporting current hypotheses of how the cortico-BG circuitry works to select motor and emotional actions, and how defects in this circuitry can cause symptoms of the BG diseases. Emphasis is given to the role of striatal dopamine on motor performance, motivated behaviors and learning of procedural memories. Next, the use of cutting-edge electrochemical techniques in animal and human studies of BG functioning under normal and disease conditions is discussed. Finally, functional neuroimaging studies are reviewed; these works have shown the relationship between cortico-BG structures activated during DBS and improvement of disease symptoms. Copyright © 2015. Published by Elsevier Ltd.
    Neuroscience & Biobehavioral Reviews 02/2015; DOI:10.1016/j.neubiorev.2015.02.003 · 10.28 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: The pathophysiology of the tics that define Gilles de la Tourette syndrome (TS) is not well understood. Local disinhibition within the striatum has been hypothesized to play a pathogenic role. In support of this, experimental disinhibition by local antagonism of GABA-A receptors within the striatum produces tic-like phenomenology in monkey and rat. We replicated this effect in mice via local picrotoxin infusion into the dorsal striatum. Infusion of picrotoxin into sensorimotor cortex produced similar movements, accompanied by signs of behavioral activation; higher-dose picrotoxin in the cortex produced seizures. Striatal inhibition with local muscimol completely abolished tic-like movements after either striatal or cortical picrotoxin, confirming their dependence on the striatal circuitry; in contrast, cortical muscimol attenuated but did not abolish movements produced by striatal picrotoxin. Striatal glutamate blockade eliminated tic-like movements after striatal picrotoxin, indicating that glutamatergic afferents are critical for their generation. These studies replicate and extend previous work in monkey and rat, providing additional validation for the local disinhibition model of tic generation. Our results reveal a key role for corticostriatal glutamatergic afferents in the generation of tic-like movements in this model.
    Experimental Neurology 01/2015; 265. DOI:10.1016/j.expneurol.2015.01.001 · 4.62 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Gilles de la Tourette Syndrome (GTS) is a neuropsychiatric disorder characterized by multiple fluctuating motor tics and one or more phonic tics. Various treatments have been administered with limited success to patients with GTS. For more than 40 years, the medication of choice has generally been neuroleptic medication. However, unwanted side effects often occur. For those patients, Cognitive-Behavioral Therapies (CBT) have shown some success. CBT is considered an effective adjunct to medication, but the cognitive and cerebral effect of CBT has not so far been explored within a GTS population. The current research focuses on the hypothesis that significant symptom improvements in GTS, following CBT, will relate to cerebral activity changes. The aim of our research program was to compare motor Event-Related Potentials (ERP) recorded pre- and post-CBT in a population of GTS. We recorded the electroencephalogram (EEG) and derived the ERPs of 10 GTS patients, matched with 14 controls on the basis of laterality, age and intelligence. A traffic light task was administered to extract ERPs related to response processing. Results revealed that GTS had reduced cortical activation related to the inhibition of responses, which normalized following CBT. The treatment may induce cerebral changes that significantly improve both motor performances and brain activity
    International Journal of Cognitive Therapy 03/2011; 4(1):34-50. DOI:10.1521/ijct.2011.4.1.34 · 0.98 Impact Factor

Full-text (2 Sources)

Available from
May 22, 2014